Target intelligence / Profile preview

Para-aminobenzoic acid (PABA)

Target
PABA
Molecular classification
Organic compound, Benzoic acid derivative, Folate precursor, UV filter, Other
01

Overview

Para-aminobenzoic acid (PABA) is a naturally occurring organic compound and a member of the vitamin B complex, although it is not an essential nutrient for humans [1, 3]. It serves as a vital intermediate in the bacterial synthesis of folic acid, acting as a substrate for the enzyme dihydropteroate synthase (DHPS) [2, 12]. This metabolic pathway is the primary target of sulfonamide antibiotics, which are structural analogs of PABA that competitively inhibit DHPS, thereby preventing bacterial DNA synthesis and growth [12, 16]. PABA is also well-known for its ability to absorb ultraviolet B (UVB) radiation, which led to its widespread historical use as an active ingredient in sunscreens [2, 6]. Clinically, PABA and its potassium salt (Potaba) are used to treat fibrotic skin conditions such as Peyronie's disease and scleroderma, likely by enhancing oxygen uptake in tissues and suppressing fibrosis [1, 8, 16]. Additionally, PABA is utilized as a biomarker to assess the completeness of 24-hour urine collections in clinical research due to its rapid and predictable renal excretion [11, 13]. While generally safe at low doses, high systemic concentrations of PABA can lead to hepatotoxicity and may interfere with the efficacy of sulfa-based medications [1, 8, 16].

Other names
4-Aminobenzoic acidVitamin BxVitamin B10Aminobenzoic acidp-Aminobenzoic acidBacterial Vitamin H1
02

Mechanism of action

Competitive inhibition of dihydropteroate synthase (as a substrate analog); UVB radiation absorption; Antifibrotic activity via increased tissue oxygenation

03

Biological functions

Folic acid synthesisUV absorptionAntioxidantNeurotransmitter modulationCoenzyme Q synthesisOther
04

Disease associations

Bacterial infectionPeyronie's diseaseSclerodermaSunburnVitiligoOther
05

Safety considerations

Allergic contact dermatitisHepatotoxicity at high dosesInterference with sulfonamide antibiotic efficacyPhotocontact dermatitis
06

Interacting drugs

Sulfamethoxazole

4 more in the full profile.

07

Biomarkers

Urinary PABA recovery

Beyond the preview

Go deeper on Para-aminobenzoic acid (PABA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Para-aminobenzoic acid (PABA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call